Novavax says its protein-based Covid vaccine is 80% effective in young adolescents
In a good news, Novavax announced on Thursday that its Covid-19 vaccine has proved safe and effective in a study conducted on children aged between 12 to 17 years. Novavax makes a protein-based vaccine, a different type from the most widely…
Read More...
Read More...